![Ronald Pepin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Pepin
Corporate Officer/Principal at
CELLDEX THERAPEUTICS, INC.
Net worth: 764 892 $ as of 30/07/2026
Profile
Ronald A. Pepin is Director at Antyra, Inc. Dr. Pepin is Chief Business Officer & Senior Vice President at Celldex Therapeutics, Inc. since 2011.
Dr. Pepin was Executive Director-External Science & Technology at Bristol Myers Squibb Co. from 1990 to 2000.
Dr. Pepin was Senior Vice President-Business Development at Medarex, Inc. from 2000 to 2009.
Dr. Pepin was Vice President at Shire Pharmaceuticals, Inc. Dr. Pepin completed undergraduate studies at Tufts University.
Dr. Pepin earned a doctorate from Georgetown University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/06/2026 | 20,097 ( 0.03% ) | 764 892 $ | 30/07/2026 |
Ronald Pepin active positions
| Companies | Position | Start |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | 07/07/2011 |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Director/Board Member | - |
Former positions of Ronald Pepin
| Companies | Position | End |
|---|---|---|
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Corporate Officer/Principal | 31/12/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 30/06/2000 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Training of Ronald Pepin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
- Stock Market
- Insiders
- Ronald Pepin
